Mass General researchers explore how meditation can improve resiliency and prevent a decline in cognitive health, no matter what age you are.
Blog
A new study shows that the exercise hormone irisin confers the cognitive benefits of exercise on the brain and could be a new therapeutic option for Alzheimer’s disease.
In the second installment, we highlight two more approaches to Alzheimer’s research with Drs. Susanne Janneke Van Veluw and Mehdi Jorfi.
Learn how Mass General researchers are working to develop new treatments and diagnostic tools for Alzheimer’s disease and dementia.
Hoang Le, PhD, is a postdoctoral research fellow in the Genetics and Aging Research Unit.
James Quinn, PhD, is a researcher in the Alzheimer’s Clinical and Translational Research Unit (ACTRU) studying the mechanisms underlying dementia development to identify new biomarkers and novel therapeutic targets, focusing on the signaling molecules, neuropeptides. Outside the lab, James is an avid science communicator, rock climber and live music enthusiast. We all have been there—standingRead more
Alzheimer's Disease, Cardiology, Depression, Endowed MGH Research Institute Chairs | 0 comment | 23 February, 2021 | 1
The COVID-19 pandemic is only the most recent example of the central role that sex and gender play in major medical illness.
Rudy Tanzi, PhD, shares science-backed mindfulness tips to promote brain health and reduce stress as the pandemic continues.
Recent research news from the Mass General Research Institute, including insights into genetic protection from Alzheimer’s disease, heart health and more.
Alzheimer’s Disease Expert Says Future Treatment Success Will Require a Shift in Strategy and Timing
Rudy Tanzi, PhD, believes the key to treating Alzheimer’s disease will be earlier detection and treatment guided by individual risk factors and family history.